Annual SG&A
$145.88 M
+$56.81 M+63.79%
31 December 2023
Summary:
Mirum Pharmaceuticals annual selling, general & administrative expenses is currently $145.88 million, with the most recent change of +$56.81 million (+63.79%) on 31 December 2023. During the last 3 years, it has risen by +$86.66 million (+146.34%). MIRM annual SG&A is now at all-time high.MIRM Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$50.55 M
+$1.34 M+2.72%
30 September 2024
Summary:
Mirum Pharmaceuticals quarterly selling, general & administrative expenses is currently $50.55 million, with the most recent change of +$1.34 million (+2.72%) on 30 September 2024. Over the past year, it has increased by +$4.36 million (+9.44%). MIRM quarterly SG&A is now at all-time high.MIRM Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.36 B
-$99.81 M-4.41%
30 September 2024
Summary:
Mirum Pharmaceuticals TTM selling, general & administrative expenses is currently -$2.36 billion, with the most recent change of -$99.81 million (-4.41%) on 30 September 2024. Over the past year, it has dropped by -$2.51 billion (-1720.72%). MIRM TTM SG&A is now -10045.05% below its all-time high of $191.57 million, reached on 30 September 2024.MIRM TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MIRM Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +9.4% | -1720.7% |
| 3 y3 years | +146.3% | +165.5% | -4092.4% |
| 5 y5 years | +1141.3% | +1081.5% | -10000.0% |
MIRM Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +146.3% | at high | +165.5% | -122.4% | at low |
| 5 y | 5 years | at high | +1141.3% | at high | +1081.5% | -1199.0% | at low |
| alltime | all time | at high | +1141.3% | at high | >+9999.0% | <-9999.0% | at low |
Mirum Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $50.55 M(+2.7%) | $191.57 M(+7.9%) |
| June 2024 | - | $49.21 M(+7.8%) | $177.56 M(+10.1%) |
| Mar 2024 | - | $45.64 M(-1.2%) | $161.30 M(+10.6%) |
| Dec 2023 | $145.88 M(+63.8%) | $46.18 M(+26.4%) | $145.88 M(+15.6%) |
| Sept 2023 | - | $36.53 M(+10.9%) | $126.16 M(+12.5%) |
| June 2023 | - | $32.95 M(+9.0%) | $112.15 M(+12.0%) |
| Mar 2023 | - | $30.22 M(+14.2%) | $100.17 M(+12.5%) |
| Dec 2022 | $89.07 M(+50.4%) | $26.47 M(+17.6%) | $89.07 M(+9.1%) |
| Sept 2022 | - | $22.51 M(+7.4%) | $81.63 M(+6.7%) |
| June 2022 | - | $20.97 M(+9.7%) | $76.47 M(+11.1%) |
| Mar 2022 | - | $19.12 M(+0.4%) | $68.86 M(+16.3%) |
| Dec 2021 | $59.22 M | $19.04 M(+9.7%) | $59.22 M(+24.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $17.35 M(+30.0%) | $47.41 M(+32.5%) |
| June 2021 | - | $13.35 M(+40.9%) | $35.79 M(+30.2%) |
| Mar 2021 | - | $9.48 M(+31.2%) | $27.48 M(+21.1%) |
| Dec 2020 | $22.69 M(+93.1%) | $7.22 M(+26.0%) | $22.69 M(+14.9%) |
| Sept 2020 | - | $5.73 M(+13.7%) | $19.74 M(+11.4%) |
| June 2020 | - | $5.04 M(+7.5%) | $17.72 M(+17.2%) |
| Mar 2020 | - | $4.69 M(+9.7%) | $15.12 M(+28.7%) |
| Dec 2019 | $11.75 M | $4.28 M(+15.4%) | $11.75 M(+57.2%) |
| Sept 2019 | - | $3.71 M(+51.7%) | $7.47 M(+95.2%) |
| June 2019 | - | $2.44 M(+85.1%) | $3.83 M(+176.8%) |
| Mar 2019 | - | $1.32 M(+2030.6%) | $1.38 M(+2130.6%) |
| Sept 2018 | - | $62.00 K | $62.00 K |
FAQ
- What is Mirum Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly SG&A year-on-year change?
- What is Mirum Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals TTM SG&A year-on-year change?
What is Mirum Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of MIRM is $145.88 M
What is the all time high annual SG&A for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high annual selling, general & administrative expenses is $145.88 M
What is Mirum Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of MIRM is $50.55 M
What is the all time high quarterly SG&A for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $50.55 M
What is Mirum Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, MIRM quarterly selling, general & administrative expenses has changed by +$4.36 M (+9.44%)
What is Mirum Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of MIRM is -$2.36 B
What is the all time high TTM SG&A for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high TTM selling, general & administrative expenses is $191.57 M
What is Mirum Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, MIRM TTM selling, general & administrative expenses has changed by -$2.51 B (-1720.72%)